The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis.

Arthritis research & therapy

Volumn 7, Issue 3, 2005, Pages

  Keith Jr , James C ^a   Albert, Leo M ^a   Leathurby, Yelena ^a   Follettie, Max ^a   Wang, Lili ^a   Borges Marcucci, Lisa ^a   Chadwick, Christopher C ^a   Steffan, Robert J ^a   Harnish, Douglas C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; PYRAZOLE DERIVATIVE; WAY 169916; WAY-169916;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; HUMAN; LEWIS RAT; MALE; METABOLISM; PHYSIOLOGY; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIGANDS; MALE; NF-KAPPA B; PYRAZOLES; RATS; RATS, INBRED LEW; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 33644799904     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: None     Document Type: Article

References (0)